WHO Unveils First GLP-1 Obesity Guidelines, Warns Limited Access Despite Global Demand Surge
World
C
CNBC TV18•02/12/2025
WHO Unveils First GLP-1 Obesity Guidelines, Warns Limited Access Despite Global Demand Surge
- •WHO recommends GLP-1 therapies for long-term obesity treatment.
- •Guideline excludes pregnant women from GLP-1 therapy use.
- •Healthy diet and physical activity advised alongside GLP-1 drugs.
- •Obesity recognized as a chronic disease needing lifelong care.
- •Access to GLP-1 therapies remains limited, reaching <10% by 2030.
Why it matters: This impacts global obesity care and highlights ongoing barriers to treatment access.
✦
Related Articles
Loading more articles...
